AzTrials
AzTrials

Family ConflictNCT03221530

Early Intervention for Suicide Risk Among Immigrant Youth

A study testing Early Intervention for Suicide Risk Among Immigrant Youth in people with Family Conflict and Suicidal Ideation, run by Massachusetts General Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this project is to develop and test a family-based preventive intervention for suicide risk among 1st and 2nd generation immigrant Latino/a adolescents. The intervention will focus on reducing suicide risk by reducing family conflict and intergenerational cultural conflict and improving parent-child… Read more about this study

Who is it for?
Ages 12 to 15 years
Conditions the study is for
Family Conflict, Suicidal Ideation
What is being tested?
Early Intervention for Suicide Risk Among Immigrant Youth
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
1 Oct 2019to 1 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Latino
  • First generation (foreign-born) or second-generation (at least one parent foreign-born) immigrant
  • 12 to 15 years old
  • Speaks English or Spanish
  • Reports current suicidal ideation with no plan, past-year suicidal ideation, or a suicide plan more than three months prior OR has a CAT-SS score>34

Who cannot join

  • Suicide attempt in the past three months
  • Endorses psychotic symptoms on a pre-study screener
  • Has severe major depressive disorder
  • Has a prior diagnosis of severe intellectual disability
  • Receiving individual or family therapy

Trial locations and contacts

No sites are listed yet.

Kiara Alvarez, PhD contact

617-724-1237

kalvarez2@partners.org

About this study

The purpose of this project is to develop and test a family-based preventive intervention for suicide risk among 1st and 2nd generation immigrant Latino/a adolescents. The intervention will focus on reducing suicide risk by reducing family conflict and intergenerational cultural conflict and improving parent-child communication. The investigators will first develop the 8-session preventive intervention with quantitative data from analysis of existing longitudinal studies and qualitative feedback from Latino youth and their caregivers, clinicians, administrators, and research consultants, as well as results from initial pilot testing of the intervention. The investigators will then conduct a pilot randomized trial with 40 adolescents and their families to test feasibility, acceptability, and impact on intervention targets. Successful development of the intervention would improve mental health outcomes for a growing and underserved portion of the U.S. population.

Read the detailed description

Suicide is the second-leading cause of death among adolescents, with rates increasing between 1999 and 2014. Family-based preventive interventions demonstrate promise for reducing suicide risk among adolescents, and are particularly relevant for addressing suicide risk factors specific to immigrant youth, who comprise one-fourth of the U.S. population under 18. The purpose of this project is to develop and test a family-based preventive intervention for suicide risk among 1st and 2nd generation immigrant Latino/a adolescents. In the first phase of intervention development, quantitative and qualitative data will be used to develop and if necessary refine a new family based preventive intervention (Early Intervention for Suicide Risk among Immigrant Youth, EISR-I). The investigators will then test the intervention in a pilot case series in order to finalize assessment and intervention protocols. In the second phase, the investigators will pilot test the preventive intervention, delivered by mental health clinicians to 1st and 2nd generation Latino/a early adolescents and their families, in order to assess feasibility, acceptability, and impact on the intervention targets (i.e. a positive signal of the intervention) on the study population. Twenty families will be randomized to receive the 8-session intervention and twenty will receive enhanced usual care including a safety planning and feedback session.

Being tested
Early Intervention for Suicide Risk Among Immigrant Youth, Enhanced usual care
Keywords
suicidal ideation, mental health, adolescent, Latino, immigrant
Medical subject headings
Suicidal Ideation, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Intervention for Suicide Risk Among Immigrant YouthBehavioural

    The EISR-I intervention includes family treatment engagement, shared problem definition, and sessions designed to address family cohesion, communication, and conflict resolution.

  • Enhanced usual careBehavioural

    This intervention includes a session with the family to engage in safety planning and provide feedback on their baseline assessment data.

Study groups in NCT03221530
Study groupRoleWhat they receive
EISR-IExperimentalParticipants in the Early Intervention for Suicide Risk Among Immigrant Youth (EISR-I) family-based intervention will attend 8 in-person sessions with at least one parent/guardian.
Receives: Behavioral: Early Intervention for Suicide Risk Among Immigrant Youth
Enhanced usual careActive comparatorParticipants in the usual care arm will receive a safety planning and assessment feedback session from the research team and will receive usual care in the behavioral health clinic where the study takes place.
Receives: Behavioral: Enhanced usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Columbia Suicide Severity Rating Scale Screener (C-SSRS); change from baseline at multiple time points

    A self-report scale of suicidal ideation, plans and attempts

    Measured: baseline, 3, 6, and 12 months

Secondary outcomes (4)
  1. Computerized Adaptive Test - Suicide Scale (CAT-SS); change from baseline at multiple time points

    A computerized adaptive suicide scale that provides a continuous self-report measure of suicide risk

    Measured: baseline, 3, 6, and 12 months

  2. Family Relationship Index; change from baseline at multiple time points

    A self-report measure that provides an overall index of the quality of the family environment, as well as subscores that reflect family cohesion, expressiveness, and conflict.

    Measured: baseline, 3, 6, and 12 months

  3. Family Cultural Conflict Scale; change from baseline at multiple time points

    A self-report measure of conflicts within a family related to cultural values and practices.

    Measured: baseline, 3, 6, and 12 months

  4. Parent-Adolescent Communication Scale; change from baseline at multiple time points

    A self-report measure of the quality of communication between adolescent and parent.

    Measured: baseline, 3, 6, and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2017
  2. Study start1 Oct 2019 (estimated)
  3. Primary completion1 Aug 2022 (estimated)
  4. Study completion1 Aug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03221530
Sponsor's protocol ID
2017P001429
Status last verified
Aug 2019
First submitted
16 Jul 2017
Last updated
13 Aug 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Early Intervention for Suicide Risk Among Immigrant Youth in people with Family Conflict and Suicidal Ideation, run by Massachusetts General Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kiara Alvarez, PhD (617-724-1237, kalvarez2@partners.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Columbia Suicide Severity Rating Scale Screener (C-SSRS); change from baseline at multiple time points (time frame: baseline, 3, 6, and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2019; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in